AstraZeneca says it is to immediately prepare for data regulatory submission
– Says two different dosing regimens demonstrated efficacy
– One showed a vaccine efficacy of 90%
The firm’s CEO claims that the vaccine is ‘highly effective’ against the coronavirus, although the headline suggests that the development is less great as compared to what we have heard from